Cancer chemotherapy update

Jaclyn S. King, Joseph B. Farland, James Waddell, Dominic A. Solimando

Research output: Contribution to journalShort survey

Original languageEnglish (US)
Pages (from-to)228-231
Number of pages4
JournalHospital Pharmacy
Volume44
Issue number3
StatePublished - Mar 2009

Fingerprint

Chemotherapy
Drug Therapy
Neoplasms

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Pharmacy

Cite this

King, J. S., Farland, J. B., Waddell, J., & Solimando, D. A. (2009). Cancer chemotherapy update. Hospital Pharmacy, 44(3), 228-231.

Cancer chemotherapy update. / King, Jaclyn S.; Farland, Joseph B.; Waddell, James; Solimando, Dominic A.

In: Hospital Pharmacy, Vol. 44, No. 3, 03.2009, p. 228-231.

Research output: Contribution to journalShort survey

King, JS, Farland, JB, Waddell, J & Solimando, DA 2009, 'Cancer chemotherapy update', Hospital Pharmacy, vol. 44, no. 3, pp. 228-231.
King JS, Farland JB, Waddell J, Solimando DA. Cancer chemotherapy update. Hospital Pharmacy. 2009 Mar;44(3):228-231.
King, Jaclyn S. ; Farland, Joseph B. ; Waddell, James ; Solimando, Dominic A. / Cancer chemotherapy update. In: Hospital Pharmacy. 2009 ; Vol. 44, No. 3. pp. 228-231.
@article{19a1a1bebdf145ce9bc40966f5fae6b8,
title = "Cancer chemotherapy update",
author = "King, {Jaclyn S.} and Farland, {Joseph B.} and James Waddell and Solimando, {Dominic A.}",
year = "2009",
month = "3",
language = "English (US)",
volume = "44",
pages = "228--231",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "3",

}

TY - JOUR

T1 - Cancer chemotherapy update

AU - King, Jaclyn S.

AU - Farland, Joseph B.

AU - Waddell, James

AU - Solimando, Dominic A.

PY - 2009/3

Y1 - 2009/3

UR - http://www.scopus.com/inward/record.url?scp=62949088288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62949088288&partnerID=8YFLogxK

M3 - Short survey

VL - 44

SP - 228

EP - 231

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 3

ER -